A Pragmatic Trial isn’t just a Simple Trial: An Interview with Colin Baigent about ADAPTABLE cvctcardiobrief.com/a-pragmatic-tr…

Thank you to @HelenRoutledge2, Andy Epstein and the team at Worcestershire Acute Hospitals NHS Trust for randomising the 100th patient into ORBITA-2. Amazing work! Christopher Rajkumar Alex Nowbar Michael Foley

Thoughts about the use of the Win Ratio in Cardiovascular Outcome Trials cvctcardiobrief.com/thoughts-about…

#CVCT2021 Scientific Program is out there ! Go check now & register : globalcvctforum.com/scientific-pro… #CVCT Dr Roxana Mehran Harriette Van Spall, MD MPH 🇨🇦 C. Michael Gibson MD Penilla Gunther Javed Butler Larry Husten Diego Araiza MD Kevin S Shah, MD Vanessa Blumer, MD, FACC Alex Nowbar Rachna Kataria, MD Dr.Rajiv Sankaranarayanan @ersied727 Carlos G Santos-Gallego, MD

The Lowdown on the Left Atrial Appendage Occlusion Study III: an Interview with Gerhard Hindricks and Thomas F. Deering cvctcardiobrief.com/the-lowdown-on…

Our latest coronary physiology paper online now EuroIntervention. You must have heard or read before that "flow in the right coronary artery can be predominantly systolic". True, a myth or a case report bias? We investigated this formally in the large IDEAL study dataset. 1/n

Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding ⁦Rasha Al-Lamee⁩ ⁦Prof Darrel Francis ☺ Mk CardioFellows Great Again⁩ ⁦Alex Nowbar⁩ link.springer.com/article/10.100…

Calling everyone in UK that cares about the NHS. When a drug goes off patent, it becomes cheap, yeh? No. If there is only one manufacturer they can screw us over for millions. Please sign Karim Meeran's petition to the government which will fix this. petition.parliament.uk/petitions/5937…

Angina is a strange beast. rwjms1.umdnj.edu/shindler/heber…

Excited to say the SAMSON Trial's full data has now been published in JACC Journals. There is lots of interesting data, such as the remarkably similar timecourses of symptom onset and offset when starting and stopping statins and placebo jacc.org/doi/10.1016/j.…

Zack asked the audience ‘what does a good medical registrar look like’ and someone wrote ‘sexy’

ORBITA-2 will provide placebo-controlled data on the efficacy of PCI on symptoms in patients off antianginal medications. An ordinal clinical outcome scale for angina was designed in partnership with patients to be a relevant and inclusive primary outcome. eurointervention.pcronline.com/article/a-doub…

Great to see this in print: methods paper for ORBITA-2. Trial is progressing well thanks to Rasha Al-Lamee Alex Nowbar & the whole team 👍

My best one? Auditing the use of continuous ECG monitoring on AMU. We've done this audit 3-4 times. Alex Nowbar Catherine Beattie Only when we implemented IT-based reminders, with buy-in from the head of the site operations team, did things start to improve.

The OphanTalent Academy #Sciathon project by Lindau Alumna Crina Samarghitean wants to connect orphan children all over the world with orphan rare diseases patients and the best researchers in the world. Help them by taking this survey: ow.ly/mpt450O2KsK

Day 1 of Lindau Nobel Laureate Meeting 2023. Honoured to be a part of this unique event #LINO23 Lindau Nobel Laureate Meetings Thank you to Mars, Incorporated and NHLI for supporting me.

Last day at Lindau 🥲 Met some wonderful people #LINO23 Lauren Owens Kayesha Coley Lindau Nobel Laureate Meetings Madeleine Dias Mirandela

A wholesome week spent in the beautiful Lindau with some amazing people 💙 #LINO23 Lindau Nobel Laureate Meetings